Literature DB >> 25762748

Influence of menstrual cycle phase on neural and craving responses to appetitive smoking cues in naturally cycling females.

Teresa R Franklin1, Kanchana Jagannathan2, Reagan R Wetherill2, Barbara Johnson2, Shannon Kelly2, Jamison Langguth2, Joel Mumma2, Anna Rose Childress2.   

Abstract

INTRODUCTION: Functional magnetic resonance imaging (fMRI) has been used extensively in an attempt to understand brain vulnerabilities that mediate maladaptive responses to drug cues. Using perfusion fMRI, we have consistently shown reward-related activation (medial orbitofrontal cortex/ventral striatum) to smoking cues (SCs). Because preclinical and clinical studies generally show that progesterone may reduce reward and craving, we hypothesized that females in the follicular phase of the cycle (FPs; when progesterone levels are low) would have greater reward-related neural responses to SCs compared with females in the luteal phase (LPs).
METHODS: Sated cigarette-dependent premenopausal naturally cycling females underwent pseudo-continuous arterial spin-labeled perfusion fMRI during exposure to 10-min audio visual clips of appetitive SCs and non-SCs. Brain responses to SCs relative to non-SCs were examined among females grouped according to menstrual cycle (MC) phase at the time of scanning (22 FPs, 15 LPs). Craving scores were acquired pre- and post-SC exposure.
RESULTS: FPs showed increased neural responses to SCs compared with non-SCs in the medial orbitofrontal cortex (p ≤ .05 corrected), whereas LPs did not. FPs reported SC-elicited craving (p ≤ .005), whereas LPs did not. Within FPs, SC-induced craving correlated with increased neural responses in the anterior insula (r = 0.73, p < .0001).
CONCLUSIONS: FPs may be more vulnerable to relapse during appetitive SC exposure than LPs. Because the influence of MC phase on drug cue neural activity has not been examined, these results contribute to our knowledge of the neurobiological underpinnings of responses to drug cues, and they highlight the importance of monitoring menstrual cycle phase in all areas of addiction research.
© The Author 2015. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 25762748      PMCID: PMC4432396          DOI: 10.1093/ntr/ntu183

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  61 in total

1.  Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding.

Authors:  E C Donny; A R Caggiula; P P Rowell; M A Gharib; V Maldovan; S Booth; M M Mielke; A Hoffman; S McCallum
Journal:  Psychopharmacology (Berl)       Date:  2000-09       Impact factor: 4.530

2.  Sex differences in the contribution of nicotine and nonpharmacological stimuli to nicotine self-administration in rats.

Authors:  Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Sheri Booth; Maysa A Gharib; Laure A Craven; Shannon S Allen; Alan F Sved; Kenneth A Perkins
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

3.  A functional magnetic resonance imaging (FMRI) study of cue-induced smoking craving in virtual environments.

Authors:  Jang-Han Lee; Youngsik Lim; Brenda K Wiederhold; Simon J Graham
Journal:  Appl Psychophysiol Biofeedback       Date:  2005-09

Review 4.  Sex differences in drug abuse.

Authors:  Jill B Becker; Ming Hu
Journal:  Front Neuroendocrinol       Date:  2007-08-24       Impact factor: 8.606

5.  Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity.

Authors:  Eric D Claus; Sara K Blaine; Francesca M Filbey; Andrew R Mayer; Kent E Hutchison
Journal:  Neuropsychopharmacology       Date:  2013-05-24       Impact factor: 7.853

6.  Individual differences in cue reactivity among smokers trying to quit: effects of gender and cue type.

Authors:  R Niaura; W G Shadel; D B Abrams; P M Monti; D J Rohsenow; A Sirota
Journal:  Addict Behav       Date:  1998 Mar-Apr       Impact factor: 3.913

7.  Association between ovarian hormones and smoking behavior in women.

Authors:  Crystal Edler Schiller; Michael E Saladin; Kevin M Gray; Karen J Hartwell; Matthew J Carpenter
Journal:  Exp Clin Psychopharmacol       Date:  2012-04-30       Impact factor: 3.157

Review 8.  Hormones, nicotine, and cocaine: clinical studies.

Authors:  Nancy K Mello
Journal:  Horm Behav       Date:  2009-10-14       Impact factor: 3.587

9.  DAT genotype modulates brain and behavioral responses elicited by cigarette cues.

Authors:  Teresa R Franklin; Falk W Lohoff; Ze Wang; Nathan Sciortino; Derek Harper; Yin Li; Will Jens; Jeffrey Cruz; Kyle Kampman; Ron Ehrman; Wade Berrettini; John A Detre; Charles P O'Brien; Anna Rose Childress
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

10.  Memory retrieval of smoking-related images induce greater insula activation as revealed by an fMRI-based delayed matching to sample task.

Authors:  Amy C Janes; Robert S Ross; Stacey Farmer; Blaise B Frederick; Lisa D Nickerson; Scott E Lukas; Chantal E Stern
Journal:  Addict Biol       Date:  2013-11-22       Impact factor: 4.280

View more
  24 in total

Review 1.  Sex Differences in Animal Models: Focus on Addiction.

Authors:  Jill B Becker; George F Koob
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

2.  Multi-site exploration of sex differences in brain reactivity to smoking cues: Consensus across sites and methodologies.

Authors:  Kelly M Dumais; Teresa R Franklin; Kanchana Jagannathan; Nathan Hager; Michael Gawrysiak; Jennifer Betts; Stacey Farmer; Emily Guthier; Heather Pater; Amy C Janes; Reagan R Wetherill
Journal:  Drug Alcohol Depend       Date:  2017-07-08       Impact factor: 4.492

3.  Effect of Selective Inhibition of Reactivated Nicotine-Associated Memories With Propranolol on Nicotine Craving.

Authors:  Yan-Xue Xue; Jia-Hui Deng; Ya-Yun Chen; Li-Bo Zhang; Ping Wu; Geng-Di Huang; Yi-Xiao Luo; Yan-Ping Bao; Yu-Mei Wang; Yavin Shaham; Jie Shi; Lin Lu
Journal:  JAMA Psychiatry       Date:  2017-03-01       Impact factor: 21.596

4.  Exercise or saccharin during abstinence block estrus-induced increases in nicotine-seeking.

Authors:  Wendy J Lynch; Lillian Tan; Syeda Narmeen; Rebecca Beiter; Darlene H Brunzell
Journal:  Physiol Behav       Date:  2017-10-31

5.  Shifted balance of dorsal versus ventral striatal communication with frontal reward and regulatory regions in cannabis-dependent males.

Authors:  Feng Zhou; Kaeli Zimmermann; Fei Xin; Dirk Scheele; Wolfgang Dau; Markus Banger; Bernd Weber; René Hurlemann; Keith M Kendrick; Benjamin Becker
Journal:  Hum Brain Mapp       Date:  2018-09-12       Impact factor: 5.038

Review 6.  Sex and gender differences in substance use disorders.

Authors:  R Kathryn McHugh; Victoria R Votaw; Dawn E Sugarman; Shelly F Greenfield
Journal:  Clin Psychol Rev       Date:  2017-11-10

7.  Oral Contraceptives and Cigarette Smoking: A Review of the Literature and Future Directions.

Authors:  Alicia M Allen; Andrea H Weinberger; Reagan R Wetherill; Carol L Howe; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2019-04-17       Impact factor: 4.244

8.  Exogenous progesterone for smoking cessation in men and women: a pilot double-blind, placebo-controlled randomized clinical trial.

Authors:  Nicole L Tosun; Ann M Fieberg; Lynn E Eberly; Katherine A Harrison; Angela R Tipp; Alicia M Allen; Sharon S Allen
Journal:  Addiction       Date:  2019-06-17       Impact factor: 6.526

Review 9.  Role of Exogenous Progesterone in the Treatment of Men and Women with Substance Use Disorders: A Narrative Review.

Authors:  MacKenzie R Peltier; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2018-05       Impact factor: 5.749

10.  Sex-related differences in subjective, but not neural, cue-elicited craving response in heavy cannabis users.

Authors:  Shikha Prashad; Ryan P Hammonds; Amanda L Wiese; Amber L Milligan; Francesca M Filbey
Journal:  Drug Alcohol Depend       Date:  2020-02-19       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.